Clinical Trial Update: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing entecavir plus adefovir versus entecavir alone and versus adefovir plus lamivudine in chronic hepatitis B patients with lamivudine-resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir dipivoxil (Hepsera) (adefovir dipivoxil)
• Entecavir (Baraclude) (Entecavir)
• Lamivudine (Epivir) (lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04